JSJang-Won Son

Jang-Won Son

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jang-Won Son has a total of 138 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Echocardiographic drag effect index and its association with response to mavacamten in obstructive hypertrophic cardiomyopathy

    by Hyun-Su Ha, Sang Gon Yoon, Seokchul Cho, Hee Jeong Lee, In-Cheol Kim, Hyungseop Kim, Jang-Won Son, Jong-Ho Nam, Kang-Un Choi, Hyun-Jung Lee, et al.

    Aims: Despite mavacamten’s effect on left ventricular outflow tract (LVOT) obstruction, clinical response is heterogeneous. Considering the central role of systolic anterior motion (SAM) in obstruction, we examined whether mitral geometry and SAM-related echocardiographic indices correlate with this variability in obstructive hypertrophic cardiomyopathy (HCM) patients. Methods and results: A total of 128 patients with obstructive HCM were included in this multi-centre observational study. The SAM-related echocardiographic parameters—including anterior and posterior leaflet lengths, residual leaflet length (RL), protrusion height, and aortomitral angle (α)—were measured. A drag effect index was quantified by sin(α) × RL. Clinical response was defined as achieving a lowest observed Valsalva-induced LVOT gradient of less than 30 mmHg at any point during the 12-week follow-up period. Among the 128 patients, 33 (25.8%) were non-responders. Non-responders had a smaller α (115.3 ± 8.3° vs. 125.7 ± 9.9°; P < 0.001), longer RL (1.1 ± 0.2 vs. 0.8 ± 0.3, P < 0.001), and higher drag effect index values (sin(α) × RL; 1.0 ± 0.2 vs. 0.7 ± 0.3; P < 0.001). Multivariable logistic regression identified resting LVOT gradient, α, and drag effect index as independent factors associated with non-response. Receiver operating characteristic analysis demonstrated moderate discriminative ability for α [area under the curve (AUC) 0.787], RL (AUC 0.754), and strong discriminatory ability for the drag effect index (AUC 0.825), with the drag effect index providing the highest overall accuracy (73%). Conclusion: Drag-based echocardiographic indices offered high discriminatory performance for mavacamten response. Integrating these patient-specific metrics into routine assessment provides valuable pathophysiological insights into SAM mechanisms in obstructive HCM.


  • Open Access

    Preprocedural Left Atrial Strain as a Predictor of Long‐Term Outcomes Following Mitral Valve Interventions in Rheumatic Severe Mitral Stenosis

    by Sang Gon Yoon, Dae‐Young Kim, Iksung Cho, Seo‐Yeon Gwak, Kyu Kim, Hyun‐Jung Lee, Chi Young Shim, Jong‐Won Ha, In‐Cheol Kim, Ha Jeong Lim, et al.

    Background: This study explores whether preprocedural left atrial (LA) strain predicts outcomes in individuals with rheumatic, severe mitral stenosis undergoing mitral valve (MV) interventions. Methods: Data were from the MASTER (Multicenter Mitral Stenosis with Rheumatic Etiology) registry, including patients with severe mitral stenosis who underwent percutaneous mitral valvuloplasty or MV replacement. Participants with moderate or greater dysfunction of other valves or missing strain data were excluded. The primary outcome was a composite of all‐cause mortality and heart failure hospitalization. Decreased LA reservoir strain was defined as P =0.001). Multivariate analysis showed decreased LA strain (hazard ratio [HR], 2.04 [95% CI, 1.06–3.93]; P =0.001), older age, and higher right ventricular systolic pressure were independent predictors of adverse outcomes. Conclusions: Preprocedural decreased LA reservoir strain was associated with adverse clinical outcomes after MV intervention in individuals with severe mitral stenosis. These findings suggest that LA strain could serve as a marker for optimizing the timing of MV intervention.


  • Open Access

    Patient-Centric Approach to Improve the Quality of Life and Healing Efficacy for Patients With Fabry Disease: A Grounded Theory-Based Analysis

    by Seo-Yeon Gwak, Ha Jeong Lim, Iksung Cho, Chi Young Shim, Kyu Kim, Hyun-Jung Lee, Jang-Won Son, Geu-Ru Hong

    Gwak SY, et al. J Korean Med Sci. 2026 Apr;41(16):e132. https://doi.org/10.3346/jkms.2026.41.e132

  • Open Access

    Sarcopenia in atrial fibrillation: a risk factor for adverse outcomes in a UK Biobank study

    by Hong-Ju Kim, Pil-Sung Yang, Hanjin Park, Daehoon Kim, Han-Joon Bae, Chan-Hee Lee, Jang-Won Son, Ung Kim, Boyoung Joung

    Aims: Sarcopenia, characterized by reduced muscle mass and function, has been increasingly implicated in cardiovascular disorders. However, its prognostic relevance in atrial fibrillation (AF) remains unclear. We aimed to evaluate the association between sarcopenia and adverse outcomes in individuals with AF using UK Biobank data. Methods and results: This retrospective cohort study included individuals with AF enrolled between 2006 and 2010 at 22 centres. Sarcopenia was defined per European Working Group on Sarcopenia in Older People 2 (EWGSOP2) criteria as low muscle strength and/or low muscle mass measured by handgrip and bioelectrical impedance analysis. Propensity score weighting adjusted for baseline differences. The primary outcome was a composite of all-cause mortality, major bleeding, thromboembolic events (stroke/systemic embolism), and heart failure admission; each component was also assessed individually. Among 5144 patients with AF (median age, 64.0 years; 24.1% female), 16.7% had sarcopenia. After propensity score weighting, sarcopenia was associated with a higher incidence of the primary composite outcome [43.9 per 1000 person-years (PYRs)], with an adjusted hazard ratio (HR) of 1.30 [95% confidence interval (CI), 1.15–1.46]. This risk was mainly driven by elevated rates of all-cause mortality (26.4 per 1000 PYRs; aHR, 1.44; 95% CI 1.24–1.68) and major bleeding (14.4 per 1000 PYRs; aHR, 1.34; 95% CI 1.10–1.65). Subgroup analyses demonstrated consistent results. Conclusion: Even after PS weighting analysis, some residual confounders may remain; however, sarcopenia was independently associated with adverse clinical outcomes, particularly mortality and bleeding risk. Screening for sarcopenia may enhance risk stratification and management, particularly in patients receiving anticoagulation.


  • Long-Term Follow-Up in Severe Mitral Stenosis With Low Transmitral Diastolic Pressure Gradient: From MASTER Registry

    by Iksung Cho, Dae-Young Kim, Jinseob Kim, Ha Jeong Lim, Jiwon Seo, Kyu Kim, Seo-Yeon Gwak, Hyun-Jung Lee, Hee Jeong Lee, Kyu-Yong Ko, et al.

    BACKGROUND: Long-term follow-up studies in severe mitral stenosis (MS) with low transmitral mean diastolic pressure gradient (MDPG) are not available. We evaluated the prognostic implications of severe MS with low MDPG in our MASTER (Multicenter Mitral Stenosis with Rheumatic Etiology) registry. METHODS: We included patients with severe rheumatic MS (mitral valve area ≤1.5 cm 2 ) from the long-term MASTER registry. Patients were categorized into high (≥5 mm Hg) or low (P =0.004), and low MDPG was independently associated with poor outcome (hazard ratio, 1.42 [95% CI, 1.02–1.97]; P =0.038) in the multivariable model. In the subgroup analysis of patients with low MDPG, decreased left atrial reservoir strain was independently associated with poor outcome (hazard ratio, 3.22 [95% CI, 1.25–8.31]; P =0.016). CONCLUSIONS: Patients with severe MS and low MDPG carried a greater risk of adverse events than those with high MDPG and had less frequent and delayed mitral valve intervention. Also, it is not necessarily indicative of milder hemodynamic encumbrance. Left atrial reservoir strain could help identify a subgroup associated with poor prognosis in patients with low MDPG.


  • The Evolving Landscape of Hypertrophic Cardiomyopathy

    by Jang-Won Son, Jong-Ho Nam, Kang-Un Choi, Geu-Ru Hong

  • Selecting the optimal candidates for percutaneous mitral valvuloplasty using multi-modality imaging

    by Hee Jeong Lee, Na Young Kim, Dae-Young Kim, Jang-Won Son, Kang-Un Choi, SeonHwa Lee, In-Cheol Kim, Kyu-Yong Ko, Kyung Eun Ha, Seo-Yeon Gwak, et al.

    Aims: This study compared echocardiography (echo) and cardiac computed tomography (CT) in measuring the Wilkins score and evaluated the potential added benefit of CT in predicting immediate percutaneous mitral valvuloplasty (PMV) outcomes in rheumatic mitral stenosis (MS) patients deemed eligible for PMV by echo. Methods and results: From a multicentre registry of 3,140 patients with at least moderate MS, we included 96 patients (age 56.4 ± 11.5 years, 81% female) eligible for PMV based on echo Wilkins score (≤9) who underwent PMV and had measurable CT and echo images. We compared Wilkins scores from both modalities and analysed their relationship with unsuccessful procedural outcomes, defined as sub-optimal post-procedural mitral valve area (<1.5 cm2) or newly developed mitral regurgitation Grade ≥III. The mean CT score was higher than the echo score (8.0 ± 2.4 vs. 7.3 ± 1.2 points, P = 0.005). Procedural success was achieved in 65 (67.7%) patients. Unsuccessful results occurred in 31 patients, primarily in intermediate echo score (7–9 points) group. Among patients with intermediate echo scores, 90% had high CT scores (≥9), which were associated with significantly higher rates of unsuccessful PMV compared with lower CT scores (61.1 vs. 18.9%, P < 0.001). Conclusion: CT-derived Wilkins scores were higher than echo-derived scores, with the most significant discrepancy in the intermediate echo score group. CT identified a subgroup of patients at higher risk for unsuccessful PMV among those with intermediate echo-based feasibility. Patients with intermediate echo-based PMV feasibility may benefit from CT-based reclassification, potentially improving patient selection and procedural outcomes.


  • Open Access

    Real-time three-dimensional transthoracic echocardiographic segmental volume analysis: a quantitative and objective tool for assessing regional left ventricle wall motion in patients with ischemic heart disease

    by Jin-Hwan Kwak, Kang-Un Choi, Jong-Ho Nam, Chan-Hee Lee, Ung Kim, Jong-Seon Park, Jang-Won Son

    Background: Evaluation of regional left ventricle function using two-dimensional echocardiography (2DE) in patients with ischemic heart disease has limitations due to its low objectivity and qualitative nature. In addition, 2DE is limited because multiple acoustic windows are used to obtain the image, whereas three-dimensional echocardiography (3DE) uses a single window. This study aims to demonstrate the clinical utility of 3DE segmental volume analysis for evaluating regional wall motion abnormality (RWMA). Methods: This retrospective study included 33 patients with ischemic heart disease and single-vessel territory RWMA confirmed on coronary angiography. RWMA was visually assessed using 2DE, generating 17-segment bull's-eye polar maps, and 3DE. In the 3DE study, two independent observers analyzed segmental volumes and segmental volume ejection fractions (SVEFs) using QLAB 3D quantification software. The optimal SVEF cutoff value differentiating normal from abnormal was determined using receiver operating curve analysis. The accuracy of 3DE in predicting culprit coronary arteries was compared with that of 2DE using Cohen κ coefficients, which also were used for interobserver and intraobserver variability assessments. Results: Mean 3DE SVEFs were significantly lower in segments showing RWMA on 2DE. The optimal SVEF cutoff value was 44%, with sensitivity of 75.0% and specificity of 73.9% (area under the curve, 0.801; 95% CI, 0.763–0.838; P < 0.001). The reliability of 3DE-derived bull's-eye predictions of culprit coronary arteries was 81.8% (κ = 0.672; 95% CI, 0.555–0.789; P < 0.001). Interobserver and intraobserver variabilities were 97.0% (κ = 0.947; 95% CI, 0.894–1.00; P < 0.001) and 93.9% (κ = 0.897; 95% CI, 0.827–0.967; P < 0.001), respectively. Conclusions: The 3DE segmental volume analysis effectively quantified regional left ventricle function and aligned well with 2DE and coronary angiography findings in predicting culprit coronary arteries. Thus, 3DE segmental volume analysis can serve as a quantitative and objective tool for RWMA assessment in patients with ischemic heart disease.


  • Open Access

    Complete or incomplete revascularization in patients with left main culprit lesion acute myocardial infarction with multivessel disease: a retrospective observational study

    by Sun Oh Kim, Hong-Ju Kim, Jong-Il Park, Kang-Un Choi, Jong-Ho Nam, Chan-Hee Lee, Jang-Won Son, Jong-Seon Park, Sung-Ho Her, Ki-Yuk Chang, et al.

    Background: Complete revascularization has demonstrated better outcomes in patients with acute myocardial infarction (AMI) and multivessel disease. However, in the case of left main (LM) culprit lesion AMI with multivessel disease, there is limited evidence to suggest that complete revascularization is better.Methods: We reviewed 16,831 patients in the Korea Acute Myocardial Infarction Registry who were treated from July 2016 to June 2020, and 399 patients were enrolled with LM culprit lesion AMI treated with percutaneous coronary intervention. We categorized the patients as those treated with complete revascularization (n=295) or incomplete revascularization (n=104). The study endpoint was major adverse cardiac and cerebrovascular events (MACCE), a composite of all-cause death, myocardial infarction, ischemia-driven revascularization, stent thrombosis, and stroke. We performed propensity score matching (PSM) and analyzed the incidence of MACCE at 1 year.Results: After PSM, the two groups were well balanced. There was no significant difference between the two groups in MACCE at 1 year (12.1% vs. 15.2%; hazard ratio, 1.28; 95% confidence interval, 0.60–2.74; p=0.524) after PSM. The components of MACCE and major bleeding were also not significantly different.Conclusion: There was no significant difference in clinical outcomes between the groups treated with complete or incomplete revascularization for LM culprit lesion AMI with multivessel disease.